Daniel Ramirez

Verified profile

Angel/Individual · United States

Daniel Ramirez is an angel investor based in the United States. They invest in Pharmaceuticals. Their portfolio includes Remedly, Combinostics, Triage and Talk Life and 2 other companies.

Industries

Portfolio companies (6)

  • Remedly
  • Combinostics
  • Triage
  • Talk Life
  • Pacifica Labs
  • SkinVision

Similar investors in Pharmaceuticals

  • Jeff ParksVerified

    Angel/Individual, Investment Partner · United States

    SeedHealth CareHospitalsBig DataPharmaceuticals

    Portfolio: Loku, OMNY

    Contact details available

  • Nicholas Bashour

    Private Equity Firm · United States

    AdvertisingHealth CareCommercialHospitals

    Portfolio: Linius Technologies, LDI

    Contact details available

  • Thomas Parkinson

    Venture Capital, Government Office, Private Equity Firm · United States

    Health CareTelecommunicationsAutonomous VehiclesCybersecurity

    Portfolio: Adrenaline Mobility, EarthSense, Inc.

    Contact details available

  • Travis WoodVerified

    Venture Capital, Private Equity Firm, Venture Debt · United States

    AdvertisingHealth CarePaymentsCybersecurity

    Portfolio: Welcome Software, Ecast

    Contact details available

  • Leigh Randall

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedConsumer Goods

    Portfolio: Codagenix

    Contact details available

  • Maya Hardigan

    Venture Capital, Founder, CEO · United States

    SeedConsumer HealthElectronic Health Records (EHR)Health and Hospital ServicesDigital Health

    Contact details available

  • Alex IsmailVerified

    Private Equity Firm · United States

    Local CommerceHealth CareTelecommunicationsHospitals

    Portfolio: GFL Environmental, NueHealth

    Contact details available

  • Rafael RomeroVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsE-commerceWomen Founded

    Portfolio: Frequency Therapeutics, Lev Pharmaceuticals

    Contact details available